OUR LATEST POST

curevac-myneo-colaboration

CureVac exercises options in strategic collaboration with myNEO Therapeutics.

CureVac has exercised its options on a selected set of potential cancer vaccine targets identified by myNEO Therapeutics under the existing partnership agreement Two option fee payments triggered to myNEO Therapeutics By applying its AI-based ImmunoEngine platform,...

ALL POSTS

All
News
Press release
Article
Team events
Load More
Load More
Load More
Load More

Innovating immunotherapies,
transforming tomorrow

Subscribe to our newsletter

Get the latest news & updates about myNEO Therapeutics

Home

About us

Products

Technology

Partners

Services

Contact

Quick links

Publications

Latest news

Privacy statement

Terms of use

Careers

Cookie statement

We use cookies to enhance your browsing experience and provide analytics. By continuing to use this website, you agree to our use of cookies. For more information, please read our privacy statement.

myNEO Therapeutics

Ottergemsesteenweg 439
9000 Ghent
Belgium

Design by

© 2023 - myNEO Therapeutics